Departments of Emergency Medicine.
Spleen and Stomach and Hepatology, The Kunshan Hospital Affiliated to Nanjing University of Chinese Medicine.
J Clin Gastroenterol. 2022 Feb 1;56(2):e114-e120. doi: 10.1097/MCG.0000000000001656.
The goal of this study was to further determine the role of lactated Ringer (LR) compared with normal saline (NS) in managing acute pancreatitis (AP) as a consideration of fluid resuscitation.
Fluid resuscitation play a critically important role in managing AP, and NS and LR solutions were common selection in clinical practice. However, it remains debate about which regime may be more better for patients with AP.
The PubMed, Embase, and the Cochrane library were searched to find eligible randomized controlled trials focusing on the comparative efficacy and safety of LR and NS for the management of patients with AP.
Four eligible randomized controlled trials involving 248 patients to perform meta-analysis finally. Meta-analysis suggested no statistical difference between LR and NS groups in reducing the incidence of systemic inflammatory response syndrome at 24 hours [risk ratio (RR)=0.66, 95% confidence interval (CI)=0.33-1.31, P=0.24], 48 hours (RR=0.70, 95% CI=0.29-1.68, P=0.42), and 72 hours (RR=0.68, 95% CI=0.37-1.25, P=0.22). Meanwhile, no statistical difference was detected between LR and NS groups in terms of in-hospital mortality, incidence of local complications, pancreatic necrosis, organ failure, and developing moderate-to-severe AP, and the length of hospital stay. However, incidence of intensive care unit admission in LR group was significantly lower than that in NS group (RR=0.39, 95% CI=0.18-0.85; P=0.02).
The current updated meta-analysis indicates that LR may be superior to NS in managing patients with AP because of LR has a potential advantage in decreasing the incidence of pancreatic necrosis and intensive care unit admission compared with NS.
本研究旨在进一步确定乳酸林格氏液(LR)与生理盐水(NS)在作为液体复苏考虑因素时,用于治疗急性胰腺炎(AP)的作用。
液体复苏在管理 AP 中起着至关重要的作用,NS 和 LR 溶液是临床实践中的常见选择。然而,关于哪种方案对 AP 患者更有效仍存在争议。
检索了 PubMed、Embase 和 Cochrane 图书馆,以寻找关于 LR 和 NS 治疗 AP 患者的比较疗效和安全性的合格随机对照试验。
最终有四项合格的随机对照试验纳入了 248 名患者进行荟萃分析。荟萃分析表明,LR 组与 NS 组在 24 小时[风险比(RR)=0.66,95%置信区间(CI)=0.33-1.31,P=0.24]、48 小时(RR=0.70,95% CI=0.29-1.68,P=0.42)和 72 小时(RR=0.68,95% CI=0.37-1.25,P=0.22)时全身性炎症反应综合征的发生率方面无统计学差异。同时,LR 组与 NS 组在住院死亡率、局部并发症发生率、胰腺坏死、器官衰竭和中重度 AP 的发生以及住院时间方面无统计学差异。然而,LR 组的重症监护病房入住率明显低于 NS 组(RR=0.39,95% CI=0.18-0.85;P=0.02)。
目前的更新荟萃分析表明,LR 可能优于 NS,因为与 NS 相比,LR 在降低胰腺坏死和重症监护病房入住率方面具有潜在优势。